Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells.

Abstract:

:In the current study, we investigated whether the naive, poly I:C or interleukin-2 (IL-2)-induced natural killer (NK)/lymphokine-activated killer (LAK) cells use perforin and/or Fas ligand (FasL) to mediated cytotoxicity. We correlated these findings with the ability of mice to reject syngeneic Fas+ and Fas- tumor cells either spontaneously or after IL-2 treatment. The spontaneous NK-cell-mediated cytotoxicity was primarily perforin based, whereas the poly I:C and IL-2-induced NK/LAK activity was both FasL and perforin dependent. L1210 Fas+ tumor targets were more sensitive than L1210 Fas- targets to poly I:C and IL-2-induced cytotoxicity in wild-type, gld/gld, and perforin knockout mice. When L1210 Fas+ and Fas- tumor cells were injected subcutaneously (sc) or intraperitoneally into syngeneic mice, Fas- tumor cells caused mortality earlier than Fas+ tumor cells. Also, approximately 20% of the mice injected sc with L1210 Fas+ tumor cells survived the challenge(>60 days), whereas all mice injected similarly with L1210 Fas- tumor cells died. When immunotherapy using IL-2 (10,000 U, three times/d for a week, followed by once/d for an additional week) was attempted in mice injected sc with tumor cells, IL-2 treatment was very effective against mice bearing L1210 Fas+ (40% survival) but not L1210 Fas- (0% survival) tumors. These data correlated with the finding that the LAK cells from IL-2-injected mice caused increased cytotoxicity against L1210 Fas+ when compared with L1210 Fas- targets. Also, L1210 Fas+ tumor-bearing mice showed increased tumor-specific cytotoxic T lymphocyte (CTL) activity when compared with those bearing L1210 Fas- tumor cells. Together our studies show for the first time that expression of Fas on tumor targets makes them more immunogenic as well as susceptible to CTL- and IL-2-induced LAK activity. The Fas+ tumor cells are also more responsive to immunotherapy with IL-2.

journal_name

Blood

journal_title

Blood

authors

Bradley M,Zeytun A,Rafi-Janajreh A,Nagarkatti PS,Nagarkatti M

subject

Has Abstract

pub_date

1998-12-01 00:00:00

pages

4248-55

issue

11

eissn

0006-4971

issn

1528-0020

journal_volume

92

pub_type

杂志文章

相关文献

BLOOD文献大全
  • The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis.

    abstract::Dendritic cell (DC) development is efficiently supported by Flt3-ligand or GM-CSF in vitro, and lymphoid-organ DC maintenance in vivo is critically dependent on Flt3-ligand. However, the relevance of GM-CSF for lymphoid-tissue DC maintenance and the importance of both cytokines for nonlymphoid organ DC homeostasis are...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-206318

    authors: Kingston D,Schmid MA,Onai N,Obata-Onai A,Baumjohann D,Manz MG

    更新日期:2009-07-23 00:00:00

  • Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion.

    abstract::Integrin-β7 (ITGB7) mRNA is detected in multiple myeloma (MM) cells and its presence is correlated with MAF gene activation. Although the involvement of several integrin family members in MM-stoma cell interaction is well documented, the specific biologic functions regulated by integrin-β7 in MM are largely unknown. C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-06-292243

    authors: Neri P,Ren L,Azab AK,Brentnall M,Gratton K,Klimowicz AC,Lin C,Duggan P,Tassone P,Mansoor A,Stewart DA,Boise LH,Ghobrial IM,Bahlis NJ

    更新日期:2011-06-09 00:00:00

  • Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

    abstract::Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplant reflects a complex immune response resulting in chronic damage to multiple tissues. Previous studies indicated that donor B cells and the antibodies they produce play an important role in the development of cGVHD. To understa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-08-801001

    authors: Wang KS,Kim HT,Nikiforow S,Heubeck AT,Ho VT,Koreth J,Alyea EP,Armand P,Blazar BR,Soiffer RJ,Antin JH,Cutler CS,Ritz J

    更新日期:2017-12-28 00:00:00

  • Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.

    abstract::Fanconi anemia (FA) is an autosomal recessive syndrome characterized by progressive bone marrow failure and cancer predisposition. Eight FA complementation groups have been identified. The FANCA, FANCC, FANCE, FANCF, and FANCG proteins form a nuclear complex required for the monoubiquination of the FANCD2 protein. To ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-11-3517

    authors: Gordon SM,Buchwald M

    更新日期:2003-07-01 00:00:00

  • Characterization of Grb2-binding proteins in human platelets activated by Fc gamma RIIA cross-linking.

    abstract::Glutathione-S-transferase (GST)-Grb2 fusion proteins have been used to identify the potential role of Grb2-binding proteins in platelet activation by the platelet low-affinity IgG receptor, Fc gamma RIIA. Two tyrosine phosphoproteins of 38 and 63 kD bind to the SH2 domain of Grb2 following Fc gamma RIIA stimulation of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Robinson A,Gibbins J,Rodríguez-Liñares B,Finan PM,Wilson L,Kellie S,Findell P,Watson SP

    更新日期:1996-07-15 00:00:00

  • Identification of talin head domain as an immunodominant epitope of the antiplatelet antibody response in patients with HIV-1-associated thrombocytopenia.

    abstract::HIV-1-associated thrombocytopenia (HIV-1-ITP) is a common complication of HIV-1 infection, frequently caused by increased peripheral platelet destruction mediated by antiplatelet antibodies (Abs) and/or platelet-bound immune complexes. Little is known about the specificity of the antiplatelet Abs at a molecular level....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0386

    authors: Koefoed K,Ditzel HJ

    更新日期:2004-12-15 00:00:00

  • Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.

    abstract::Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called "synthetic lethality" was applied, which relies on the addic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-05-501072

    authors: Cramer-Morales K,Nieborowska-Skorska M,Scheibner K,Padget M,Irvine DA,Sliwinski T,Haas K,Lee J,Geng H,Roy D,Slupianek A,Rassool FV,Wasik MA,Childers W,Copland M,Müschen M,Civin CI,Skorski T

    更新日期:2013-08-15 00:00:00

  • Platelet αIIbβ3 activation: filling in the pieces.

    abstract::In this issue of Blood, Kasirer-Friede and colleagues show that the adhesion and degranulation promoter protein (ADAP) promotes αIIbβ3 activation by presenting the cytoplasmic proteins talin and kindlin to the β3 cytoplasmic tail. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-02-557355

    authors: Bennett JS

    更新日期:2014-05-15 00:00:00

  • Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia.

    abstract::The purpose of this study was to define, in a phase I study in leukemia, the maximally tolerated dose (MTD), major toxicities, and possible antitumor activity of Topotecan, a new topoisomerase I (topo I) inhibitor. Topotecan was delivered by a 5-day continuous infusion every 3 to 4 weeks to patients with refractory or...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Kantarjian HM,Beran M,Ellis A,Zwelling L,O'Brien S,Cazenave L,Koller C,Rios MB,Plunkett W,Keating MJ

    更新日期:1993-03-01 00:00:00

  • International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

    abstract::Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction caused by a cytokine storm often including interleukin-6. iMCD accou...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-10-746933

    authors: Fajgenbaum DC,Uldrick TS,Bagg A,Frank D,Wu D,Srkalovic G,Simpson D,Liu AY,Menke D,Chandrakasan S,Lechowicz MJ,Wong RS,Pierson S,Paessler M,Rossi JF,Ide M,Ruth J,Croglio M,Suarez A,Krymskaya V,Chadburn A,Colleoni

    更新日期:2017-03-23 00:00:00

  • Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.

    abstract::We have previously shown that the plant-derived compound parthenolide (PTL) can impair the survival and leukemogenic activity of primary human acute myeloid leukemia (AML) stem cells. However, despite the activity of this agent, PTL also induces cellular protective responses that likely function to reduce its overall ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-278044

    authors: Hassane DC,Sen S,Minhajuddin M,Rossi RM,Corbett CA,Balys M,Wei L,Crooks PA,Guzman ML,Jordan CT

    更新日期:2010-12-23 00:00:00

  • Heterogeneity in filamentous actin content among individual human blood platelets.

    abstract::The content of filamentous actin in individual platelets was measured by flow cytometry, using a fluorescent probe specific for filamentous actin (F-actin), 7-nitrobenz-2-oxa-1,3-phallacidin (NBD-phallacidin). NBD-phallacidin binding to fixed platelets was specific in that either pretreatment of platelets with unlabel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Oda A,Daley JF,Cabral C,Kang JH,Smith M,Salzman EW

    更新日期:1992-02-15 00:00:00

  • Chronic lymphocytic leukemia and the Warburg effect.

    abstract::In this issue of Blood, Jitschin et al demonstrate a microenvironmental glycolytic shift in chronic lymphocytic leukemia (CLL) cells mediated by Notch-c-Myc signaling. Interfering in the Notch-c-Myc pathway and reprogramming glycolytic metabolism could contribute to overcoming drug resistance in CLL. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-04-636332

    authors: Moreno C

    更新日期:2015-05-28 00:00:00

  • Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

    abstract::An acquired gain-of-function mutation in the Janus kinase 2 (JAK2-V617F) is frequently found in patients with myeloproliferative disorders (MPDs). To test the hypothesis that JAK2-V617F is the disease-initiating mutation, we examined whether all cells of clonal origin carry the JAK2-V617F mutation. Using allele-specif...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2005-11-009605

    authors: Kralovics R,Teo SS,Li S,Theocharides A,Buser AS,Tichelli A,Skoda RC

    更新日期:2006-08-15 00:00:00

  • Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin.

    abstract::Previous studies have shown that bone marrow, especially the bone microenvironment, may play an important role in the pathogenesis of multiple myeloma (MM). To elucidate the relationship between myeloma cells and bone cells, mainly osteoblasts, we have established a coculture system between two interleukin-6 (IL-6)-de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Barillé S,Collette M,Bataille R,Amiot M

    更新日期:1995-10-15 00:00:00

  • Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells.

    abstract::We examined the expression of messenger RNA (mRNA) of the human inducible nitric oxide synthase (hiNOS) gene in a panel of human T-cell lines. Reverse transcriptase-polymerase chain reaction showed that human T-cell leukemia virus type-I (HTLV-I)-infected T-cell lines (MT-1, SLB-1, and C5/MJ) expressed mRNA for the hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mori N,Nunokawa Y,Yamada Y,Ikeda S,Tomonaga M,Yamamoto N

    更新日期:1999-10-15 00:00:00

  • Changes in activities and isozyme patterns of glycolytic enzymes during erythroid differentiation in vitro.

    abstract::Late committed progenitor cells of erythropoiesis, CFU-E (colony-forming unit--erythroid), were isolated from mouse spleens to near homogeneity by a three-step enrichment procedure. The procedure included a four-day pretreatment of bled mice with the antibiotic thiamphenicol, a recovery period of 3 1/2 days, followed ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nijhof W,Wierenga PK,Staal GE,Jansen G

    更新日期:1984-09-01 00:00:00

  • Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10.

    abstract::Virally infected cells degrade intracellular viral proteins proteolytically and present the resulting peptides in association with major histocompatibility complex (MHC) class I molecules to CD8+ cytotoxic T lymphocytes (CTLs). These cells are normally prone to CTL-mediated elimination. However, several viruses have e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zeidler R,Eissner G,Meissner P,Uebel S,Tampé R,Lazis S,Hammerschmidt W

    更新日期:1997-09-15 00:00:00

  • Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.

    abstract::This study was performed to assess the utility of tumor-derived fragmentary DNA, or circulating tumor DNA (ctDNA), for identifying high-risk patients for relapse of acute myeloid leukemia and myelodysplastic syndrome (AML/MDS) after undergoing myeloablative allogeneic hematopoietic stem cell transplantation (alloSCT)....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-10-880690

    authors: Nakamura S,Yokoyama K,Shimizu E,Yusa N,Kondoh K,Ogawa M,Takei T,Kobayashi A,Ito M,Isobe M,Konuma T,Kato S,Kasajima R,Wada Y,Nagamura-Inoue T,Yamaguchi R,Takahashi S,Imoto S,Miyano S,Tojo A

    更新日期:2019-06-20 00:00:00

  • BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study.

    abstract::An inverse relationship between BCL-2 expression and cell cycle transition has been suggested by recent studies in murine models. To investigate the clinical relevance of these laboratory studies, a group of 116 paraffin-embedded non-Hodgkin's lymphoma (NHL) biopsy specimens (Working Formulation Groups D-H, and J) fro...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Winter JN,Andersen J,Reed JC,Krajewski S,Variakojis D,Bauer KD,Fisher RI,Gordon LI,Oken MM,Jiang S,Jeffries D,Domer P

    更新日期:1998-02-15 00:00:00

  • A 2.7-kb portion of the 5' flanking region of the murine glycoprotein alphaIIb gene is transcriptionally active in primitive hematopoietic progenitor cells.

    abstract::The continuous generation of mature blood cells from primitive multipotent progenitor cells requires a highly complex series of cellular events that are still largely unknown. To examine the molecular events associated with the commitment of these hematopoietic progenitor cells to the megakaryocytic lineage, the alpha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tropel P,Roullot V,Vernet M,Poujol C,Pointu H,Nurden P,Marguerie G,Tronik-Le Roux D

    更新日期:1997-10-15 00:00:00

  • The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.

    abstract::Numerous studies have suggested that iron (Fe) chelators such as desferrioxamine (DFO) may be useful antitumor agents (Blatt and Stitely, Cancer Res 47:1749, 1987; Becton and Bryles, Cancer Res 48:7189, 1988). Recent work with several analogues of the lipophilic Fe chelator, pyridoxal isonicotinoyl hydrazone (PIH), in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Richardson DR,Tran EH,Ponka P

    更新日期:1995-12-01 00:00:00

  • A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users.

    abstract::Infection with human T-cell leukemia virus type II (HTLV-II) has been associated with rare chronic T-cell malignancies and has recently been demonstrated in a significant proportion of American intravenous drug abusers (IVDA). Identification of an HTLV-II-infected cohort of IVDA has allowed analysis of the HTLV-II car...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rosenblatt JD,Plaeger-Marshall S,Giorgi JV,Swanson P,Chen IS,Chin E,Wang HJ,Canavaggio M,Hausner MA,Black AC

    更新日期:1990-07-15 00:00:00

  • Pattern of pyruvate kinase isozymes in erythroleukemia cell lines and in normal human erythroblasts.

    abstract::To further investigate the erythroid nature of the two human erythroleukemia cell lines, K562 and HEL-60, and to define the ontogeny of pyruvate kinase (PK) isozymes (R, M2) in developing human erythroid cells, we have studied the isozymic alterations, if any, during differentiation of these cell lines in vitro and no...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Max-Audit I,Testa U,Kechemir D,Titeux M,Vainchenker W,Rosa R

    更新日期:1984-10-01 00:00:00

  • Defective delivery of iron to the developing red cell of the Belgrade laboratory rat.

    abstract::Erythroid cell iron and transferrin uptake and release was studied in the anemia of the Belgrade laboratory rat (gene symbol, b), an autosomal recessive trait characterized by hypochromia and hyperferrinemia. When reticulocyte-rich red cells were incubated in vitro with doubly (59Fe, 125I) labeled transferrin, b/b cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Edwards JA,Sullivan AL,Hoke JE

    更新日期:1980-04-01 00:00:00

  • Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.

    abstract::MCL-1 is a Bcl-2 family member that has been described as antiapoptotic in various myeloid neoplasms. Therefore, MCL-1 has been suggested as a potential new therapeutic target. Systemic mastocytosis (SM) is a myeloid neoplasm involving mast cells (MCs) and their progenitors. In the present study, we examined the expre...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-032714

    authors: Aichberger KJ,Mayerhofer M,Gleixner KV,Krauth MT,Gruze A,Pickl WF,Wacheck V,Selzer E,Müllauer L,Agis H,Sillaber C,Valent P

    更新日期:2007-04-01 00:00:00

  • Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10).

    abstract::An unbalanced translocation der(1;7)(q10; p10) is a nonrandom chromosomal aberration commonly observed in myelodysplastic syndrome and acute myeloid leukemia. We molecularly analyzed the breakpoints of der(1;7)(q10;p10) by quantitative fluorescent in situ hybridization (FISH) analyses using centromeric satellite DNAs ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0031

    authors: Wang L,Ogawa S,Hangaishi A,Qiao Y,Hosoya N,Nanya Y,Ohyashiki K,Mizoguchi H,Hirai H

    更新日期:2003-10-01 00:00:00

  • Hypercytokinemia in familial hemophagocytic lymphohistiocytosis.

    abstract::Familial hemophagocytic lymphohistiocytosis (FHL) is a frequently missed and almost uniformly fatal childhood disorder. It is characterized by fever, hepatosplenomegaly, cytopenia, coagulopathy, and hypertriglyceridemia. The pathogenesis of FHL is not known but the above clinical and laboratory findings are compatible...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Henter JI,Elinder G,Söder O,Hansson M,Andersson B,Andersson U

    更新日期:1991-12-01 00:00:00

  • Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s.

    abstract::Prophylactic treatment in severe hemophilia is very effective but is limited by cost issues. The implementation of 2 different prophylactic regimens in The Netherlands and Sweden since the 1970s may be considered a natural experiment. We compared the costs and outcomes of Dutch intermediate- and Swedish high-dose prop...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-470898

    authors: Fischer K,Steen Carlsson K,Petrini P,Holmström M,Ljung R,van den Berg HM,Berntorp E

    更新日期:2013-08-15 00:00:00

  • Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.

    abstract::Wilms' tumor 1 (WT1) is constantly expressed in leukemic cells of acute leukemia and myelodysplastic syndrome (MDS). A T-cell receptor (TCR) that specifically reacts with WT1 peptide in the context of HLA-A*24:02 has been identified. We conducted a first-in-human trial of TCR-gene transduced T-cell (TCR-T-cell) transf...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-06-791202

    authors: Tawara I,Kageyama S,Miyahara Y,Fujiwara H,Nishida T,Akatsuka Y,Ikeda H,Tanimoto K,Terakura S,Murata M,Inaguma Y,Masuya M,Inoue N,Kidokoro T,Okamoto S,Tomura D,Chono H,Nukaya I,Mineno J,Naoe T,Emi N,Yasukawa M,

    更新日期:2017-11-02 00:00:00